Literature DB >> 19754305

Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.

Kürsat Gündogan1, Fahri Bayram, Mehmet Capak, Fatih Tanriverdi, Ahmet Karaman, Ahmet Ozturk, Hasan Altunbas, Cumali Gökce, Ali Kalkan, Cevad Yazici.   

Abstract

BACKGROUND: Metabolic syndrome has become a public health challenge worldwide. The aim of this study was to determine the prevalence of and risk factors for metabolic syndrome among adults in the Mediterranean region of Turkey.
METHODS: This study included a total of 767 people from 20 to 83 years old from 4 provinces calculated with respect to results of the 2000 census. People from the city centers, districts, and villages were selected by a stratified sampling method. Personal histories were recorded. Weight, height, and waist and hip circumferences were measured. Blood samples were obtained to determine glucose, total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides. Components of metabolic syndrome were modified from both Adult Treatment Panel III (ATP III) and International Diabetes Federation (IDF) criteria.
RESULTS: The prevalence of metabolic syndrome was 34.6% (male, 31.2%; female, 37.3%) (P > 0.05) and 28.8% (male, 23.1%; female, 33.5% (P < 0.01) according to IDF criteria and ATP III, respectively. The highest prevalence of metabolic syndrome was present in subjects aged 60-69 years; in obese people (43.2%, P < 0.001); in Hatay province (36.5%, P < 0.001); and in districts (32.2%, P > 0.05). The prevalence of metabolic syndrome criteria in all 4 provinces was as follows: type 2 diabetes mellitus, 15%; hypertension, 41.4%; obesity, 44.1%; abdominal obesity, 56.8%; low HDL-C, 34.1%; hypertriglyceridemia, 35.9%; and high LDL-C, 27.4%.
CONCLUSIONS: The high prevalence of metabolic syndrome in this region is an important public health problem that may cause an increase in mortality. Urgent preventive measurements should be implemented.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19754305     DOI: 10.1089/met.2008.0068

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  26 in total

1.  Evaluation of mean platelet volume in patients with type 2 diabetes mellitus and blood glucose regulation: a marker for atherosclerosis?

Authors:  Kemal Turker Ulutas; Recep Dokuyucu; Fatih Sefil; Erhan Yengil; Ahmet Taner Sumbul; Hatice Rizaoglu; Ihsan Ustun; Erkan Yula; Tevfik Sabuncu; Cumali Gokce
Journal:  Int J Clin Exp Med       Date:  2014-04-15

2.  Pediatric-specific reference intervals in a nationally representative sample of Iranian children and adolescents: the CASPIAN-III study.

Authors:  Roya Kelishadi; Hamid Reza Marateb; Marjan Mansourian; Gelayol Ardalan; Ramin Heshmat; Khosrow Adeli
Journal:  World J Pediatr       Date:  2015-12-18       Impact factor: 2.764

Review 3.  Prevalence of hypertension and pre-hypertension in the Middle East region: a systematic review & meta-analysis.

Authors:  Hassan Okati-Aliabad; Alireza Ansari-Moghaddam; Shiva Kargar; Mahdi Mohammadi
Journal:  J Hum Hypertens       Date:  2022-01-15       Impact factor: 2.877

4.  Antihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly mild to moderate essential hypertensive patients with or without metabolic syndrome: a pooled post hoc analysis of two comparative trials.

Authors:  Stefano Omboni; Ettore Malacco; Jean-Michel Mallion; Massimo Volpe
Journal:  Drugs Aging       Date:  2012-12       Impact factor: 3.923

5.  Rest-activity rhythms in emerging adults: implications for cardiometabolic health.

Authors:  Elissa K Hoopes; Melissa A Witman; Michele N D'Agata; Felicia R Berube; Benjamin Brewer; Susan K Malone; Michael A Grandner; Freda Patterson
Journal:  Chronobiol Int       Date:  2021-01-13       Impact factor: 2.877

6.  Metabolic syndrome in estonia: prevalence and associations with insulin resistance.

Authors:  Triin Eglit; Tarvo Rajasalu; Margus Lember
Journal:  Int J Endocrinol       Date:  2012-02-25       Impact factor: 3.257

7.  Prevalence of metabolic syndrome and related factors in bank employees according to different defining criteria, Vitória/ES, Brazil.

Authors:  Luciane Bresciani Salaroli; Renata Aubin Dias Saliba; Eliana Zandonade; Maria del Carmen Bisi Molina; Nazaré Souza Bissoli
Journal:  Clinics (Sao Paulo)       Date:  2013-01       Impact factor: 2.365

8.  Prevalence of the metabolic syndrome in a rural population in Ghana.

Authors:  Mawuli Gyakobo; Albert Gb Amoah; De-Anne Martey-Marbell; Rachel C Snow
Journal:  BMC Endocr Disord       Date:  2012-10-30       Impact factor: 2.763

9.  Metabolic syndrome and its correlated factors in an urban population in South West of Iran.

Authors:  Hajieh Shahbazian; Seyed Mahmoud Latifi; Mohammad Taha Jalali; Heshmatollah Shahbazian; Reza Amani; Abdolrasool Nikhoo; Armaghan Moravej Aleali
Journal:  J Diabetes Metab Disord       Date:  2013-02-08

10.  Metabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adults.

Authors:  Kursat Gundogan; Fahri Bayram; Vedia Gedik; Ahmet Kaya; Ahmet Karaman; Ozgür Demir; Tevfik Sabuncu; Derya Kocer; Ramazan Coskun
Journal:  Arch Med Sci       Date:  2013-04-12       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.